Advanced Enzyme Technologies Ltd Share Price

Pharmaceuticals

NSE: ADVENZYMES Small Cap ISIN: INE837H01020

As on 20 March 2025 at 21:17 IST

₹288.25

+ 10.05

(3.61%)

Sell Buy

Over 1 Month

-7.84%

Over 6 Months

-46.44%

Over 1 Year

-20.47%

Over 3 Years

-8.65%

Advanced Enzyme Technologies Ltd Summary

Close ₹288.25

Open ₹279.60

High ₹290

Low ₹277.75

Volume 2,59,963

Net Turnover (in Cr) ₹7.42

52Wk High ₹571

52Wk Low ₹257.90

52Wk High / Low

257.90

571

Advanced Enzyme Technologies Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹3,224.96

EPS (TTM) 9.47

Book Value (BV) 53.82

Div. Yield 1.77 %

P/E (TTM) 34.07

Price/Book Value 5.35

Delivery % 53.96 %

Face Value 2

Key Ratios

PE Ratio 35.94

PB Ratio 6.69

EV to Sales 10.59

PEG Ratio 0.38

ROA 18.56

ROE 22.29

Debt-Equity -

Net Profit Margin 33.72

Operating Profit Margin 44.93

Advanced Enzyme Technologies Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	660.53	566.09	535.80	510.69	449.63
Total Expenses	457.58	421.64	364.75	300.56	270.47
Profit Before Tax	187.82	140.39	171.06	210.13	179.16
Profit After Tax	136.95	103.87	123.80	151.29	133.05
Operating Profit after Depreciation	205.88	146.87	172.85	211.74	182.19

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	660.11	654.94	624.55	609.56	568.25
Total Non Current Assets	725.72	699.74	663.17	640.16	603.03
Total Current Assets	809.74	722.11	604.44	516.01	375.57
TOTAL ASSETS	1,535.46	1,421.85	1,267.61	1,156.17	978.61
Total Shareholder's Fund	1,324.13	1,235.07	1,088.59	970.94	839.65

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	141.37	140.36	122.29	162.97	140.90
Net Cash used in Investing Activities	-64.80	-285.50	1.65	-27.33	-42.74
Net Cash used in Financing Activities	-59.24	-25.80	-48.50	-26.39	-38.55

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	424.28	321.34	281.88	290.30	256.36
Total Expenses	271.34	247.06	209.81	191.87	180.50
Profit Before Tax	133.99	74.28	72.07	98.43	75.85
Profit After Tax	108.12	55.53	54.51	71.01	57.95
Operating Profit after Depreciation	153.10	74.41	72.17	98.53	76.95

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	147.54	148.28	137.46	137.60	132.33
Total Non Current Assets	384.59	386.26	352.94	329.37	297.31
Total Current Assets	248.34	189.54	176.69	160.23	125.36
TOTAL ASSETS	632.93	575.80	529.62	489.60	422.68
Total Shareholder's Fund	580.47	525.33	480.35	435.45	370.48

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	55.81	50.30	37.10	84.23	45.98
Net Cash used in Investing Activities	-6.88	-42.35	-14.24	-69.91	-24.94
Net Cash used in Financing Activities	-56.88	-11.99	-10.87	-15.49	-18.56

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	169.11	146.10	154.52	157.82	160.94
Total Expenses	113.86	103.68	103.36	102.44	107.18
Profit Before Tax	53.03	42.21	48.67	39.62	58.88
Profit After Tax	38.88	33.39	34.98	29.87	42.50
Operating Profit after Depreciation	62.94	52.04	58.15	64.88	68.16

Particulars (in ₹ Cr.)	2024-12	2024-09	2024-06	2024-03	2023-12
Total Revenue	100.87	77.38	85.96	92.40	91.14
Total Expenses	78.81	63.86	65.04	63.16	66.59
Profit Before Tax	20.54	12.32	72.16	10.38	25.36
Profit After Tax	15.18	9.13	67.06	3.14	19.12
Operating Profit after Depreciation	23.49	15.18	74.80	32.45	28.12

Advanced Enzyme Technologies Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 273.67

S2 269.13

S3 265.87

Pivot 276.93

R1 281.47

R2 284.73

R3 289.27

Moving Average

20 SMA 279.02

50 SMA 310.88

100 SMA 352.36

200 SMA 393.42

Advanced Enzyme Technologies Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Advanced Enzyme Technologies Ltd

₹1.1/Share

Announcement Date 18 Jul 2024

Record Date 18 Jul 2024

Div Yield 55%

AGM Date: 19 Aug 2022

AGM 19/08/2022 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (as amended) read with Schedule III of the SEBI Listing Regulations, and in furtherance to our letter dated July 21, 2022 intimating about the 33rd Annual General Meeting of the Company ('AGM'), please find enclosed the Notice of 33rd AGM of the Company scheduled to be held on Friday, August 19, 2022 at 10:00 a.m. (IST) through Video Conference ('VC') or Other Audio Visual Means ('OAVM'), which is also being sent by electronic mode to the Members of the Company. The aforesaid Notice of 33rd AGM is also uploaded on the website of the Company (As Per BSE Announcement Dated on 27.07.2022) CORRIGENDUM - NOTICE OF THE 33RD ANNUAL GENERAL MEETING OF ADVANCED ENZYME TECHNOLOGIES LIMITED (As Per BSE Announcement Dated on 30/07/2022) Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 details regarding the voting results, based on the Scrutinizers report dated August 19, 2022 is enclosed. Also, Consolidated Scrutinizer Report dated August 19, 2022 on remote e-voting and electronic voting during the AGM is enclosed. Advanced Enzyme Technologies Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 20.08.2022)

AGM Date: 12 Aug 2023

Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 , it is hereby informed that Record Date has been fixed as Saturday, August 05, 2023, for the purpose of ascertaining the entitlement of the Members to the final dividend for FY 2023, if approved(declared) at the 34th AGM 34th Annual General Meeting of the Company will be held on Saturday, August 12, 2023, through Video Conference/ Other Audio Visual Means ( VC/OAVM) Notice of 34th AGM of the Company Scheduled to be held on Saturday, August 12, 2023 at 3:00 p.m. (IST) through Video Conference ('VC') or Other Audio Visual Means ('OAVM') (As Per BSE Announcement dated on 13.07.2023) Newspaper Publication informing the members inter-alia regarding the 34th AGM of the Company, Annual Report for financial year 2022-23 and the AGM notice sent by electronic mode(email). (As Per BSE Announcement Dated on 14.07.2023) Proceedings of 34th Annual General Meeting held on August 12, 2023. (As per BSE Announcement Dated on 12/08/2023)

AGM Date: 25 Jul 2024

This is to inform that the 35th Annual General Meeting of the Company will be held on Thursday, July 25, 2024. Record Date has been fixed as Thursday July 18, 2024 for the purpose of ascertaining the entitlement of the members to the Final Dividend for FY24, if approved (declared) at the 35th AGM. Notice of 35th Annual General Meeting of the Company (As Per BSE Announcement dated on 01.07.2024) Proceedings of 35th Annual General Meeting (AGM) held on July 25, 2024 Consolidated report of the Scrutinizer and details regarding voting results of 35th Annual General Meeting of the Company held on July 25, 2024 (As Per BSE Announcement Dated on: 25/07/2024)

Advanced Enzyme Technologies Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceuticals Industries Ltd	₹1,750.10	₹4,19,907.61
Divis Laboratories Ltd	₹5,823.70	₹1,54,600.94
Cipla Ltd	₹1,513.05	₹1,22,196.18
Torrent Pharmaceuticals Ltd	₹3,229.90	₹1,09,309.58
Dr Reddys Laboratories Ltd	₹1,186.65	₹99,020.65

Advanced Enzyme Technologies Ltd Top Mutal Funds Invested

Fund Name	AUM
ICICI Pru P.H.D Fund	1.41%
UTI-MNC Fund	1.03%
ICICI Pru ESG Exclusionary Strategy Fund	1.67%
HDFC Multi Cap Fund	0.09%
Bank of India Small Cap Fund	0.67%

Advanced Enzyme Technologies Ltd News

Advanced Enzyme Technologies allots 500 equity shares under ESOS

19 Mar 2025, 03:59 pm

Advanced Enzyme Techs. to announce Quarterly Result

On 8 February 2025

03 Feb 2025, 10:25 am

Advanced Enzymes announces incorporation of new entity in California for laboratory testing services

05 Dec 2024, 12:56 pm

Advanced Enzyme Tech drops after PAT slides 5% YoY in Q2 FY25

Advanced Enzyme Technologies tumbled 11.93% to Rs 427.60 after the company reported 4.59% decline in consolidated net profit to Rs 32.83 crore on a 7.44% slide in revenue from operations to Rs 1,460.95 crore in Q2 FY25 over Q2 FY24.

11 Nov 2024, 01:57 pm

Advanced Enzyme Techs. announces board meeting date

On 9 November 2024

02 Nov 2024, 01:55 pm

Advanced Enzyme Technologies Ltd Stock Analysis

Annual revenue for Advanced Enzyme Technologies Ltd increased by 32.04% to ₹424.28 crore in FY 2024 from ₹321.34 crore in FY 2023.
Annual Net Profit for Advanced Enzyme Technologies Ltd increased by 94.72% to ₹108.12 crore in FY 2024 from ₹55.53 crore in FY 2023.
Promoter Shareholding in Advanced Enzyme Technologies Ltd decreased by 0.05% in the most recent quarter, from 42.95% in September 2024 to 42.93% in December 2024.
Advanced Enzyme Technologies Ltd delivered a 1-year return of -20.47% compared to the Nifty 50, which provided a return of 5% as of the last trading session.
Advanced Enzyme Technologies Ltd share price moved up by 3.61% from its previous close of INR ₹278.20. The latest Advanced Enzyme Technologies Ltd share price is INR ₹288.25.
Advanced Enzyme Technologies Ltd share price today has been at a low of 277.75 and a high of 290. Over the past 52 weeks, the Advanced Enzyme Technologies Ltd share price has seen a low of 257.90 and a high of 571.